Lion Biotechnologies
NASDAQ: IOVANew York, US · Delaware corporation
Founders & leadership
MC
Molly C. HendersonExecutive
MT
Michael T. LotzeExecutive
SA
Steven A. FischkoffExecutive
MF
Maria FardisExecutive
Board
JV
Jay VenkatesanBoard director
WR
Wayne RothbaumBoard director
MM
Merrill McPeakBoard director
SJ
Sanford J, HillsbergBoard director
RM
Ryan MaynardBoard director
Reported raises · per SEC filings
Form D private placements$100M disclosed across 1 round · 2016
▶$100MraisedJun 2016 · 24 investors · BiotechnologyRule 506(b)
▶$100MraisedJun 2016 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Molly C. HendersonExecutive Officer
- Michael T. LotzeExecutive Officer
- Merrill McPeakDirector
- Steven A. FischkoffExecutive Officer
- Sanford J, HillsbergDirector
- Jay VenkatesanDirector
- Wayne RothbaumDirector
- Maria FardisExecutive Officer, Director
- Ryan MaynardDirector
- Offering amount
- $100M
- Amount sold
- $100M
- Sales commissions
- $4M
- Placement agents
- Piper Jaffray & Co., Jefferies LLC
- First sale
- Jun 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Lion Biotechnologies raised?
- Lion Biotechnologies has disclosed $100M raised across 1 round.
- Where is Lion Biotechnologies headquartered?
- Lion Biotechnologies is headquartered in New York, US.